3-tyr-octreotide has been researched along with paclitaxel in 1 studies
Studies (3-tyr-octreotide) | Trials (3-tyr-octreotide) | Recent Studies (post-2010) (3-tyr-octreotide) | Studies (paclitaxel) | Trials (paclitaxel) | Recent Studies (post-2010) (paclitaxel) |
---|---|---|---|---|---|
95 | 2 | 4 | 31,874 | 5,729 | 15,395 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bandyopadhyay, AK; Banerjee, I; Chattopadhyay, S; De, K; Dey, G; Ganguly, S; Gupta, A; Mandal, M; Misra, M; Mukherjee, D; Mukherjee, M | 1 |
1 other study(ies) available for 3-tyr-octreotide and paclitaxel
Article | Year |
---|---|
Paclitaxel-loaded solid lipid nanoparticles modified with Tyr-3-octreotide for enhanced anti-angiogenic and anti-glioma therapy.
Topics: Animals; Cell Line, Tumor; Drug Carriers; Glioma; Lipids; Mice; Nanoparticles; Neovascularization, Pathologic; NIH 3T3 Cells; Octreotide; Paclitaxel; Rats | 2016 |